'Truly Practice Changing' Trial in Gastroesophageal Cancer

(MedPage Today) — SAN FRANCISCO — Incorporating the recently approved bispecific antibody zanidatamab (Ziihera) into first-line treatment for HER2-positive gastroesophageal cancer topped trastuzumab plus chemotherapy, a phase III trial showed…

Source link : https://www.medpagetoday.com/meetingcoverage/mgics/119319

Author :

Publish date : 2026-01-07 20:16:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

‘Truly Practice Changing’ Trial in Gastroesophageal Cancer

Acid Suppressants in Pregnancy Not Linked to Neuropsychiatric Disorders in Kids

Risky Psychedelic Retreats; Psilocybin for Binge Eating; Winter ‘SAD’ Routines

Related Posts

Opportunistic Cholesterol Gene Screens: Good in Theory Only?

Surgery Beats GLP-1 Drugs for Fat Loss, Muscle Retention, Study Suggests

Health Myths Debunked; Astronaut’s Medical Crisis; GLP-1 for Psoriatic Arthritis

Healthy living tips from the Gladiators

I Deserve to Feel Safe Where I Train and Learn

UK Approves First Drug Option for Desmoid Tumours

Opportunistic Cholesterol Gene Screens: Good in Theory Only?

Surgery Beats GLP-1 Drugs for Fat Loss, Muscle Retention, Study Suggests

Health Myths Debunked; Astronaut’s Medical Crisis; GLP-1 for Psoriatic Arthritis

Healthy living tips from the Gladiators

I Deserve to Feel Safe Where I Train and Learn

UK Approves First Drug Option for Desmoid Tumours

HT Warning Removal May Expand Use in Rheumatic Disease Care

Doctors strike called off in Scotland as union backs latest pay deal

Categories

Archives